Suppr超能文献

¹¹¹ 放射性铟标记的超细微碳颗粒;一种新型气溶胶用于肺部沉积和滞留研究。

¹¹¹Indium-labeled ultrafine carbon particles; a novel aerosol for pulmonary deposition and retention studies.

机构信息

Department of Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden.

出版信息

Inhal Toxicol. 2011 Feb;23(3):121-8. doi: 10.3109/08958378.2010.549856.

Abstract

Continuous environmental or occupational exposure to airborne particulate pollution is believed to be a major hazard for human health. A technique to characterize their deposition and clearance from the lungs is fundamental to understand the underlying mechanisms behind their negative health effects. In this work, we describe a method for production and follow up of ultrafine carbon particles labeled with radioactive ¹¹¹Indium (¹¹¹In). The physicochemical and biological properties of the aerosol are described in terms of particle size and concentration, agglomeration rate, chemical bonding stability, and human lung deposition and retention. Preliminary in vivo data from a healthy human pilot exposure and 1-week follow up of the aerosol is presented. More than 98% of the generated aerosol was labeled with Indium and with particle sizes log normally distributed around 79  nm count median diameter. The aerosol showed good generation reproducibility and chemical stability, about 5% leaching 7 days after generation. During human inhalation, the particles were deposited in the alveolar space, with no central airways involvement. Seven days after exposure, the cumulative activity retention was 95.3%. Activity leaching tests from blood and urine samples confirmed that the observed clearance was explained by unbound activity, suggesting that there was no significant elimination of ultrafine particles. Compared to previously presented methods based on Technegas, ¹¹¹In-labelled ultrafine carbon particles allow for extended follow-up assessments of particulate pollution retention in healthy and diseased lungs.

摘要

持续暴露于空气中的颗粒物污染被认为是对人类健康的主要危害之一。描述其在肺部的沉积和清除的技术对于理解其对健康的负面影响的潜在机制至关重要。在这项工作中,我们描述了一种用放射性 ¹¹¹In(¹¹¹In)标记超细微碳颗粒的方法。从气溶胶的粒径和浓度、团聚速率、化学结合稳定性以及人体肺部沉积和保留等方面描述了气溶胶的理化和生物学特性。展示了来自健康人体试验暴露和 1 周气溶胶随访的初步体内数据。生成的气溶胶中超过 98%用铟标记,粒径呈对数正态分布,计数中值直径约为 79nm。该气溶胶具有良好的生成重现性和化学稳定性,生成后 7 天的浸出率约为 5%。在人体吸入过程中,颗粒沉积在肺泡空间,没有涉及中央气道。暴露 7 天后,累积活性保留率为 95.3%。来自血液和尿液样本的活性浸出测试证实,观察到的清除是由未结合的活性引起的,这表明没有明显的超细颗粒消除。与以前基于 Technegas 的方法相比,¹¹¹In 标记的超细微碳颗粒可用于对健康和患病肺部中颗粒物污染保留的延长随访评估。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验